Assessing the Use of Mobile Technology in Adult Asthma Patients

CoheroHealth

Status: Completed

Conditions: Asthma

Treatments: Device: BreatheSmart

Study type: Interventional

Funder types: Industry

Identifiers

NCT03103880

2017 Observational Study 1.0

Details and patient eligibility

About

This is a prospective, remote observational study of adults with persistent asthma who are managed on inhaled corticosteroids.

Full description

The study consists of one interventional group and all 104 subjects will be included in this group. All subjects will be provided with the HeroTracker package, which includes:

HeroTracker sensor that counts dosage and monitors real-time medication adherence Mobile spirometer that offer remote clinical-grade lung function monitoring BreatheSmart mobile application that sends subjects real-time alerts and allows patients respond to questionnaires / surveys.

Enrollment: 104 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Ability to provide written informed consent
• Male and female adults (aged ≥ 18 years)
• Diagnosis of asthma for at least 6 months
• ICS (inhaled corticosteroid) use for at least 3 months
• Use of a pressurized metered dose inhaler (pMDI) compatible with the HeroTracker
• Possess a compatible smartphone (iOS 8.0 or higher and Android 4.3 or higher)

Exclusion criteria

• Currently pregnant or planning to become pregnant during the study period
• Primary language other than English (BreatheSmart mobile app is currently available only in English)

Trial design

Primary purpose: Health Services Research

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

104 participants in 1 patient group

BreatheSmart

Experimental group

Description:

104 subjects will be provided with the BreatheSmart platform, which consists of: HeroTracker sensor that monitors real-time asthma medication adherence Mobile spirometer that offer remote clinical-grade lung function monitoring BreatheSmart mobile application that provides patients with real-time alerts, environmental information (weather, pollution, etc.), and the ability to complete questionnaires / surveys.

Treatment:

Device: BreatheSmart